Guardian Pharmacy Services Expands Pacific Northwest Footprint with Acquisition of Washington-based Mercury Pharmacy Services
Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced its acquisition of Mercury Pharmacy Services, a leading LTC pharmacy based in Mountlake Terrace, Wash. This acquisition marks Guardian's first pharmacy location in Washington and represents one of the company's larger recent single-pharmacy deals. With this strategic addition, Guardian expands its footprint into the Pacific Northwest, positioning the company to support the growing demand for LTC pharmacy services across this area. The new location will serve residents in assisted living, skilled nursing, and behavioral health communities, as well as individuals with intellectual and developmental disabilities.
Founded in 2001, Mercury Pharmacy Services is among the largest providers of LTC pharmacy services in the Seattle-Tacoma area and serves residents and LTC communities across the state of Washington and adjoining areas. All existing leadership and staff at Mercury Pharmacy Services will remain in place, continuing to operate under the same name.
"As we continue our nationwide expansion, we remain focused on identifying outstanding local pharmacies in regions where senior living operators have expressed a clear need for high-quality, LTC pharmacy services," said Fred Burke, president and CEO of Guardian Pharmacy Services. "Demand for dependable, responsive LTC pharmacy service has grown significantly across Washington, and our acquisition of Mercury Pharmacy Services allows us to meet that need with a financially strong, high-performing pharmacy already delivering exceptional care."
As with Guardian's other acquisitions, Mercury Pharmacy Services will benefit from the company's unique business model. This enables the local pharmacy teams to focus on customer service and the specialized needs of the communities and residents they serve, while Guardian's centralized Corporate Support Team assists with the many complex behind-the-scenes business functions, including data analytics, HR, IT, payor relations, national sales and more.
Founded in 2004, Guardian Pharmacy Services has expanded from a single location to more than 50 pharmacies serving approximately 7,000 LTC facilities across the U.S. This growth has been fueled by a balanced strategy of organic expansion, greenfield startups, and acquisitions, supporting the company's success in a rapidly evolving market. For more information, visit www.guardianpharmacy.com.
About Guardian Pharmacy Services
Guardian Pharmacy Services is a leading long-term care pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of long-term health care facilities ("LTCFs") adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. As of March 31, 2025, our 51 pharmacies served approximately 189,000 residents in approximately 7,000 LTCFs across 38 states.
Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding anticipated growth, future hiring, and expanded service offerings. These statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, including those described in Guardian's periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission from time to time, and which are publicly available at www.sec.gov and via our website, investors.guardianpharmacy.com. Actual results may differ materially from those expressed or implied in these statements. Guardian Pharmacy Services undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250529903651/en/
Media Contact:
Andrew Agan, Cookerly PR
404-816-2037
[email protected]
Investor Relations Contact:
Ashley Stockton
470-995-1798
[email protected]